Patents by Inventor Carla MISSIAEN

Carla MISSIAEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sterile formulation comprising a stable phosphorothioate oligonucleotide
    Patent number: 11357790
    Abstract: A composition including a phosphorothioate oligonucleotide and at least one fatty acid and/or at least one emulsifying agent, where the composition is sterile and where the composition includes at least one agent including a thiol group and at least one phosphate compound, and the composition can be an ophthalmic composition. The present invention also relates to a method for obtaining the same and to the therapeutic use thereof.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: June 14, 2022
    Assignee: GENE SIGNAL INTERNATIONAL SA
    Inventors: Éric Viaud, Antoine Ferry, Carla Missiaen, Jo Vercammen
  • STERILE FORMULATION COMPRISING A STABLE PHOSPHOROTHIOATE OLIGONUCLEOTIDE
    Publication number: 20190350963
    Abstract: A composition including a phosphorothioate oligonucleotide and at least one fatty acid and/or at least one emulsifying agent, where the composition is sterile and where the composition includes at least one agent including a thiol group and at least one phosphate compound, and the composition can be an ophthalmic composition. The present invention also relates to a method for obtaining the same and to the therapeutic use thereof.
    Type: Application
    Filed: February 2, 2018
    Publication date: November 21, 2019
    Applicant: GENE SIGNAL INTERNATIONAL SA
    Inventors: Éric VIAUD, Antoine FERRY, Carla MISSIAEN, Jo VERCAMMEN
  • Sterile formulation comprising a stable phosphorothioate oligonucleotide
    Patent number: 10052343
    Abstract: The present invention relates to a composition comprising a phosphorothioate oligonucleotide and at least one fatty acid and/or at least one emulsifying agent, wherein said composition is sterile and wherein said composition comprises at least one agent comprising a thiol group and at least one phosphate compound, preferably said composition is an ophthalmic composition. The present invention also relates to a method for obtaining the same and to the therapeutic use thereof.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: August 21, 2018
    Assignee: GENE SIGNAL INTERNATIONAL SA
    Inventors: Eric Viaud, Antoine Ferry, Carla Missiaen, Jo Vercammen
  • Sterile Formulation Comprising a Stable Phosphorothioate Oligonucleotide
    Publication number: 20180221401
    Abstract: The present invention relates to a composition comprising a phosphorothioate oligonucleotide and at least one fatty acid and/or at least one emulsifying agent, wherein said composition is sterile and wherein said composition comprises at least one agent comprising a thiol group and at least one phosphate compound, preferably said composition is an ophthalmic composition. The present invention also relates to a method for obtaining the same and to the therapeutic use thereof.
    Type: Application
    Filed: February 3, 2017
    Publication date: August 9, 2018
    Inventors: Eric VIAUD, Antoine FERRY, Carla MISSIAEN, Jo VERCAMMEN